Presenters: Sarah Stephens, MSN, RN, Spring 2025
Textbook References:
Hinkle Chapter 12 pp. 301-366
Ricci Chapter 46 pp. 1683-1739
Key Visuals:
Diagram depicting normal cells vs cells forming a tumor.
Patient Safety Advocate:
Implement measures to promote a safe environment for patients and self.
Formulate goals and outcomes to reduce risk using evidence-based guidelines.
Member of the Profession:
Demonstrate professional attitudes and behaviors; personal accountability and growth; advocacy.
Provider of Patient-Centered Care:
Use clinical decision-making skills, develop teaching plans, integrate caring approaches, manage resources.
Member of the Healthcare Team:
Facilitate communication, collaborate effectively, function as part of an interdisciplinary team.
Identify and apply clinical judgment stages in patient care.
Demonstrate knowledge of disease processes across the lifespan.
Recognize appropriate treatments and nursing interventions for health conditions.
Utilize clinical assessment techniques effectively.
Communicate and collaborate efficiently with healthcare teams.
Integrate legal and ethical guidelines in care.
Outline nursing care during operative procedures.
Appropriate care for pregnant patients through pregnancy and postpartum.
Define cancer and related terminology.
Identify the seven warning signs of cancer (American Cancer Society).
Discuss roles of surgery, chemotherapy, radiation, and other modalities in treatment.
Recognize actions and side effects of chemotherapeutic drugs.
Understand dietary modifications related to cancer care.
Differentiate between types of radiation therapy and their side effects.
Safety precautions when caring for clients receiving radiation or chemotherapy.
Assignments:
Pre-Lecture Quiz
Concepts in Action: Cell Cycle
Interactive Tutorial: Cancer
Watch and Learn: Complications from Chemotherapy
Journal Article: Evaluating Fatigue in Prostate Cancer Patients
Common Treatments Include:
Surgery
Radiation Therapy
Chemotherapy
Hematopoietic Stem Cell Transplantation
Immunotherapy
Targeted Therapy
Hormone therapy: specific to hormone-dependent cancers (not discussed).
Prefix Meanings:
adeno-: gland
chondro-: cartilage
erythro-: red blood cell
hemangio-: blood vessels
hepato-: liver
lipo-: fat
lympho-: lymphocyte
melano-: pigment cell
myelo-: bone marrow
myo-: muscle
osteo-: bone
Carcinoma: skin, glands, mucous membranes
Sarcoma: connective tissue, muscle, bone, fat
Leukemia: blood cells
Lymphoma: lymphatic tissue
Myeloma: bone marrow
Melanoma: skin
Germ Cell: cells with 23 chromosomes
Carcinoid: hormone-producing cells
Definition: A group of disorders involving uncontrolled abnormal cell growth.
Key Dysfunctions:
Defective cell proliferation
Defective cell differentiation
Notable Terms:
Carcinogenesis: process of cancer formation.
Carcinogens: substances that promote cancer development.
Metastasis: spread of cancer cells to distant parts of the body.
Cellular Proliferation: Unregulated division of cancer cells; variations in size and structure.
Loss of Contact Inhibition: Cancer cells invade adjacent tissues without respect for boundaries.
Origin of Cancer: Can arise from any type of cell capable of evading normal growth controls.
Benign Characteristics:
Grow slowly, localized, well-defined borders, frequently encapsulated.
Do not endanger life or health.
Malignant Characteristics:
Aggressive growth and spreading
Do not respond to homeostatic controls
Irregular borders, invasive behavior, leading to severe complications.
Brain and cerebrospinal fluid
Lung
Liver
Adrenals
Bone
Potential Causes:
Viruses: HPV, Hepatitis B, Epstein-Barr linked to 10-12% of cancers.
Radiation Exposure: Carcinogenic effects.
Chemical Agents: Tobacco, dyes, and other harmful chemicals.
Genetic Factors: Chromosomal abnormalities.
Hormonal factors: Disruptions leading to increased risk.
Idiopathic: Unknown causes.
Stages of Carcinogenesis:
Initiation
Promotion
Progression
Angiogenesis (blood supply to tumors).
Mitigation of Risk: Manage lifestyle factors such as diet, obesity, inactivity, and substance use.
Chemical Agents:
Tobacco, fuel, pesticides.
Varied risks including asbestos, benzene, etc.
Genetic Risks:
BRCA1, BRCA2 for breast and ovarian cancer.
MEN1, MEN2 for multiple endocrine neoplasia.
Specific cancers: nephroblastoma, lung, prostate, colorectal, etc.
Lifestyle Risks:
Obesity, alcohol consumption, poor diet, inactivity.
Hormonal Risks:
Endogenous (natural) and exogenous (external) hormones linked to specific cancers (e.g., estrogen and breast cancer).
Recommended Actions:
Eat balanced diets, avoid carcinogens, maintain healthy weight, ensure adequate sleep, reduce stress.
Engage in regular physical activity; limit alcohol use and implement sunscreen practices.
Ensure vaccinations against HPV and HBV.
Recommendations:
Exercise regularly, avoid tobacco, eat a healthy diet, protect skin, obtain vaccinations, limit alcohol, undergo regular screenings, maintain a healthy weight, and understand family history.
Oral Cancer: Annual screenings and risk factors.
Breast Cancer: Annual mammograms start at ages 45-54; self-exams monthly.
Cervical Cancer: Pap tests every 3 years (ages 21-29); co-test every 5 years (ages 30-65).
Colon Cancer: Start screening at age 45, every 10 years until age 75.
Lung Cancer: Low-dose CT scan for ages 55-77 with relevant smoking history.
Tertiary Goals:
Address patterns and quality of care, economic impact, including hospice care and comprehensive support for patients and families.
Stages and Definitions:
T0 – No primary tumor, Tis – In situ.
T1, T2, T3, T4 – Increasing size and local extent.
N and M staging indicate regional involvement and distant spread, respectively.
Signs to Recognize:
Change in bowel or bladder habits
A sore that does not heal
Unusual bleeding or discharge
Thickening or lump in breast or elsewhere
Indigestion or dysphagia
Change in wart or mole
Persistent nagging cough or hoarseness
Tests Include:
X-ray, tissue biopsy, radiographic studies, cytology studies, PET scans, tumor markers, endoscopic exams, CBC, bone marrow evaluations, and molecular receptor status assessments.
Biopsy Methods:
Incisional, excisional, endoscopic, and needle biopsies.
Purpose: To obtain tissue samples for definitive cancer diagnosis.
Common Techniques: Upper GI, colonoscopy, genetic markers, staging methods, imaging tests including CT/MRI, and mammography.
Types of Cancer Treatment:
Surgery, chemotherapy, stem cell transplants, hematopoietic stem cell transplantation, immunotherapies - all may require combination therapies.
Types of Surgeries:
Diagnostic, staging, curative, palliative, supportive, reconstructive, preventive surgeries utilized based on clinical needs.
Combination Therapy: More effective than single agents; aim for optimal therapeutic ratio balancing effectiveness and adverse effects.
Adjuvant Therapy: Post-surgery or radiation treatment
Immunotherapy: Employs the immune system to combat cancer.
Action: Destroys cancer cells by affecting replication and DNA repair processes.
Administration Types: Varied routes based on agent type and treatment protocol including IV and regional delivery methods.
Types of Administration:
Intravenous (IV), oral, intrathecal, intraperitoneal, and intra-arterial methods utilized based on the patient's specific needs and chemotherapy protocols.
Central Line/Port: Managing and utilizing for medications while maintaining sterility and safety.
Purpose: Utilized to deliver chemotherapy directly into cerebrospinal fluid for targeted effect.
Key Points:
Monitor for extravasation, select appropriate veins, manage intravenous administration effectively.
Emphasize awareness of side effects and infections.
Symptoms to Monitor: Pain, swelling, resistance to flow; variances depend on medication type (irritants vs. vesicants).
Interventions: Stop infusion, manage symptoms, refer to physician for severe cases.
Common Effects:
Fatigue, GI issues, alopecia, stomatitis, reproductive effects, anemia, myelosuppression, and risk of infections especially during nadir.
Risks Include:
Myelosuppression, nausea, peripheral neuropathy, organ dysfunction, and various hematological concerns.
Specific drugs may lead to unique adverse effects requiring monitoring.
Importance of Pain Control:
Affects patients' quality of life significantly; both pharmacologic and non-pharmacologic approaches are necessary.
Strategies Include:
Dietary modifications, pre-treatment antiemetic administration, hydration, small frequent meals.
Key Areas of Focus:
Monitor for malnutrition, provide nutritional supplements; assess dietary preferences and engage in protein supplementation.
Mechanism: Targets specific pathways and molecules in cancer cells; including monoclonal therapies and small molecule drugs.
Common Toxicities: May lead to mucositis, GI disturbances, and notable changes in blood counts.
Strategies in Immunotherapy:
Stimulating or suppressing the immune response to enhance the killing of cancer cells; diverse types including monoclonal antibodies and CAR T-cell therapy.
Key Concerns:
Monitor for cytokine storms and neurologic toxicities; manage complications judiciously.
Educational Points:
Importance of reporting new symptoms, self-care education, and familiarity with the treatment process and potential side effects.
Mechanism of Action:
Target specific antigens on tumor cells; block pathways leading to tumor growth.
Potential Toxicities: Flulike symptoms, gastrointestinal issues, and prospects of hypertension and hepatotoxicity.
Response Actions:
Stop medications, monitor vitals, provide emergency treatment as necessary, and maintain clear documentation of events and interventions.
Purpose and Types:
Utilized in acute leukemia, with various sources for stem cells including autologous and allogeneic types.
Goals: Restore blood cell production, managing risks associated with transplant procedures.
Potential Complications:
Monitor for HSOS, graft-versus-host disease, and common post-surgical complications.
Nursing Focus: Ongoing assessments, patient support, and infection prevention strategies.
Acute and Chronic Effects:
Headache, alopecia, nausea/vomiting, potential for infertility, organ dysfunction, secondary malignancies.
Focus Areas:
Comprehensive pre-transplant evaluations, careful monitoring during treatment protocols, and follow-up care for long-term effects.
Key Considerations:
Longitudinal assessments of health and psychosocial factors; ensure family-centered support.
Causes and Types:
Recognition of acute and chronic GVHD; preventive strategies include administering immunosuppressive therapy.
Prevention Measures:
Ensure safety for immunocompromised patients; healthcare staff adhere to strict hygiene protocols.
Foods to Avoid:
Soft cheeses, undercooked meats, raw fruits and vegetables, and unpasteurized products.
Goal: Minimize infection risks during treatment.
Types:
Electromagnetic (x-rays, gamma rays) and particulate radiation (electrons, protons).
Focus: Cure, control, palliation in treatment protocols.
Methods:
External Beam Radiation Therapy (EBRT), brachytherapy, and imaging-guided techniques for precise targeting.
Procedures:
Precise imaging during treatment; special emphasis on skin care and dose monitoring.
Care Recommendations:
Monitor skin integrity, avoid harsh treatments, protect from sun exposure, and educate on treatment effects.
Techniques:
Brachytherapy methods including high and low dose modalities; patient safety remains paramount.
Protect Staff and Patients:
Private rooms, limited visit durations, and strict protocols regarding hygiene and waste disposal.
Common Effects:
Skin integrity changes, stomatitis, and other early physical side effects needing proactive management.
Monitoring Required For:
Potential for long-term effects including cognitive changes, gastrointestinal, and hormonal dysfunction.
Common Symptoms:
Fatigue, malaise, and potential alterations in bodily functions requiring attention.
Focused Care:
Enable patient coping, monitor for side effects, and support emotional needs during treatment.
Emotional and Developmental Needs:
Addressing psychosocial support for both child and family; adaptation may be necessary during treatment.
Potential Consequences:
Physical and cognitive impacts including growth issues, organ dysfunction, and psychosocial adaptations.
Safety Considerations:
Discuss treatment impacts on pregnancies; very limited treatments can be safely administered.
Key Roles:
Monitor patient conditions, document treatment responses, and provide comprehensive support.
Categories of Emergencies:
Obstructive, metabolic, infiltrative emergencies needing rapid recognition and intervention.
Symptoms to Note:
Evidence of obstructions or metabolic changes; treatments involve clinical interventions as necessary.
Focused Actions:
Immediate response protocols for severe symptoms including fluid management and urgent care transfers.
Goals:
Maintain patient's quality of life through proactive management, education, and emotional support.
Discussions Regarding Fertility:
Open dialogues regarding potential risks of cancer treatments on reproductive outcomes.
Key Factors:
Explore coping mechanisms, knowledge of support systems, and personal concerns related to illness.
Therapeutic Aims:
Prophylaxis, cure, control, and palliation to optimize quality of life for patients.
Focus Areas:
Provide compassionate care, manage symptoms, and support families through the progression of disease.
Referrals Include:
American Cancer Society, various support groups, and community resources for patients and families.